Adaptiva Expands Cross-Platform Patch Management Leadership with Support for Latest Linux, Mac, and Windows Platforms
New capabilities extend cross-platform coverage across AlmaLinux, Debian, Rocky Linux, Oracle Linux, Red Hat Enterprise Linux, and the newest macOS and Windows Server... Read more.
Brook.ai Secures $28 Million in Series B Funding, Led by UMass Memorial Health and Morningside, to Accelerate Next Phase of Growth and Innovation in Remote Care
SEATTLE, Oct. 16, 2025 /PRNewswire/ — Brook.ai is making remote care an integral part of U.S. healthcare, extending continuity of care outside the traditional... Read more.
Fathom Holdings Acquires START Real Estate to Expand First-Time Homebuyer Program Nationwide
CARY, N.C., Oct. 16, 2025 /PRNewswire/ — Fathom Holdings Inc. (Nasdaq: FTHM), a national, technology-driven real estate services platform integrating residential... Read more.
German company Eissmann with plants in Alabama and Michigan saved
Highly specialised supplier to the automotive industry with excellent growth prospects Around 3,200 jobs secured, including around 600 in the United States Growth... Read more.
Beyond the Hum Shutdown: Bouncie Leads the Way
As Hum winds down, Bouncie ensures drivers keep moving forward with seamless connectivity, trusted innovation, and peace of mind. DALLAS, Oct. 16, 2025 /PRNewswire/... Read more.
Lancium Secures $600 Million Debt Financing to Advance Clean Campus Development, Starting with 1.2 GW Abilene Site
First-of-its-kind financing package, led and structured by Santander and Cantor Fitzgerald, supports the Lancium Clean Campus in Abilene, the inaugural site of the... Read more.
CUBE ACQUIRES BERLIN-BASED KODEX AI, CREATING AN INDUSTRY-FIRST UNIFIED COMPLIANCE, RISK AND AGENTIC AI PLATFORM
Expands CUBE’s European AI footprint, unlocking new opportunities for shared insight and innovation Adds a third strategic pillar to CUBE’s RegPlatformTM,... Read more.
TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care
First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line... Read more.
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
NEW YORK, Oct. 16, 2025 /PRNewswire/ — Klotho Neurosciences, Inc. (Nasdaq: KLTO, “Klotho”, or “the Company”) a U.S.-based biogenetics... Read more.
ETHZilla names John Kristoff as SVP, Corporate Communications and Investor Relations
PALM BEACH, Fla., Oct. 16, 2025 /PRNewswire/ — ETHZilla Corporation (Nasdaq: ETHZ), a leading technology company connecting traditional finance with decentralized... Read more.